Ampio to study experimental drug in COVID-19 patients
June 19, 2020 at 08:42 AM EDT
U.S. drug developer Ampio Pharmaceuticals Inc said on Friday it would begin an early stage study of its experimental treatment, Ampion, in COVID-19 patients after it received regulatory clearance from the U.S. Food and Drug Administration.
